This phenotype is similarly seen in patients with prenatal risk factors and presumed sepsis but is modified in patients who will subsequently develop clinical sepsis with a decrease in Treg and T effector frequency, FoxP3 expression, but an increase in activated T cells. The gene discussed is FOXP3; the disease is Sepsis.